399
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Injectable microsphere/hydrogel hybrid system containing heat shock protein as therapy in a murine myocardial infarction model

, , , , , , & show all
Pages 822-829 | Received 25 Apr 2013, Accepted 21 Jul 2013, Published online: 19 Aug 2013

References

  • Park H-J, Yang F, Cho S-W. Nonviral delivery of genetic medicine for therapeutic angiogenesis. Adv Drug Deliv Rev 2012;64:40–52
  • Lange R, Weipert J, Homann M, et al. Performance of allografts and xenografts for right ventricular outflow tract reconstruction. Ann Thorac Surg 2001;71:S365–7
  • Cao L, Mooney DJ. Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev 2007;59:1340–50
  • Garbern JC, Hoffman AS, Stayton PS. Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules 2010;11:1833–9
  • Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 2011;63:300–11
  • Asoh S, Ohta S. PTD-mediated delivery of anti-cell death proteins/peptides and therapeutic enzymes. Adv Drug Deliv Rev 2008;60:499–516
  • Li Z, Guo X, Guan JA. Thermosensitive hydrogel capable of releasing bFGF for enhanced differentiation of mesenchymal stem cell into cardiomyocyte-like cells under ischemic conditions. Biomacromolecules 2012;13:1956–64
  • Acunzo J, Katsogiannou M, Rocchi P. Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol 2012;44:1622–31
  • Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 1998;83:117–32
  • Kalmar B, Greensmith L. Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev 2009;61:310–18
  • Gupta B, Levchenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 2005;57:637–51
  • Nasrollahi SA, Taghibiglou C, Azizi E, et al. Cell-penetrating peptides as a novel transdermal drug delivery system. Chem Biol Drug Des 2012;80:639–46
  • Zhang X, Zhang X, Wang F. Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application. Expert Opin Drug Deliv 2012;9:457–72
  • Kwon JH, Kim JB, Lee K-H, et al. Protective effect of heat shock protein 27 using protein transduction domain-mediated delivery on ischemia/reperfusion heart injury. Biochem Biophys Res Commun 2007;363:399–404
  • Tan C, Ban H, Kim Y-H, et al. The heat shock protein 27 (Hsp27) operates predominantly by blocking the mitochondrial-independent/extrinsic pathway of cellular apoptosis. Mol Cells 2009;27:533–8
  • Lee J, Lee KY. Injectable microsphere/hydrogel combination systems for localized protein delivery. Macromol Biosci 2009;9:671–6
  • Lee J, Bhang S, Park H, et al. Active blood vessel formation in the ischemic hindlimb mouse model using a microsphere/hydrogel combination system. Pharm Res 2010;27:767–74
  • Shin S-H, Lee J, Lim KS, et al. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis. J Control Release 2012;166:38–45
  • Lee J, Tan CY, Lee S-K, et al. Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. J Control Release 2009;137:196–202
  • Lee J, Oh YJ, Lee SK, et al. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery. J Control Release 2010;146:61–7
  • Konecny F, Zou J, Husain M, et al. Post-myocardial infarct p27 fusion protein intravenous delivery averts adverse remodelling and improves heart function and survival in rodents. Cardiovasc Res 2012;94:492–500
  • Koneru S, Varma Penumathsa S, Thirunavukkarasu M, et al. Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1. J Cell Mol Med 2008;12:2651–64
  • Lam CK, Zhao W, Cai W, et al. Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90. Circ Res 2013;112:79–89
  • Cai B, Lin Y, Xue X-H, et al. TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp Neurol 2011;227:224–31
  • Paul A, Binsalamah ZM, Khan AA, et al. A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials 2011;32:8304–18
  • Kong HJ, Lee KY, Mooney DJ. Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration. Polymer 2002;43:6239–46
  • Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003;24:4337–51
  • Tønnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002;28:621–30
  • Gombotz WR, Wee S. Protein release from alginate matrices. Adv Drug Deliv Rev 1998;31:267–85
  • Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci 2012;32:106–26
  • Won YW, Kim JK., Cha MJ, et al. Prolongation and enhancement of the anti-apoptotic effects of PTD-Hsp27 fusion proteins using an injectable thermo-reversible gel in a rat myocardial infarction model. J Control Release 2010;144:181–9
  • Shi C, Li Q, Zhao Y, et al. Stem-cell-capturing collagen scaffold promotes cardiac tissue regeneration. Biomaterials 2011;32:2508–15
  • Shimizu T, Sekine H, Yamato M, et al. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Design 2009;15:2807–14
  • Xiong Q, Hill KL, Li Q, et al. A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells 2011;29:367–75
  • Vunjak-Novakovic G, Lui KO, Tandon N, et al. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng 2011;13:245–67

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.